Tumor Cell-Specific 2′-Fluoro RNA Aptamer Conjugated with Closo-Dodecaborate as A Potential Agent for Boron Neutron Capture Therapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor Cell-Specific 2′-Fluoro RNA Aptamer Conjugated with Closo-Dodecaborate as A Potential Agent for Boron Neutron Capture Therapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 14, Pages 7326
Publisher
MDPI AG
Online
2021-07-08
DOI
10.3390/ijms22147326
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Boron Neutron Capture Therapy: A Review of Clinical Applications
- (2021) Timothy D. Malouff et al. Frontiers in Oncology
- Recent Progress and Opportunities for Nucleic Acid Aptamers
- (2021) Jonghoe Byun Life-Basel
- Modular Synthetic Approach to Carboranyl‒Biomolecules Conjugates
- (2021) Martin Kellert et al. MOLECULES
- Recent Advances in the Synthesis of High Boron-Loaded Nucleic Acids for BNCT
- (2021) Darya Sergeevna Novopashina et al. Frontiers in Chemistry
- Neutron Source Based on Vacuum Insulated Tandem Accelerator and Lithium Target
- (2021) Sergey Taskaev et al. Biology-Basel
- Boron Chemistry for Medical Applications
- (2020) Fayaz Ali et al. MOLECULES
- Functionalized mesoporous silica nanoparticles for innovative boron-neutron capture therapy of resistant cancers
- (2020) Guillaume Vares et al. Nanomedicine-Nanotechnology Biology and Medicine
- Aptamer-Based In Vivo Therapeutic Targeting of Glioblastoma
- (2020) Valeriana Cesarini et al. MOLECULES
- Boron neutron capture therapy: Current status and future perspectives
- (2020) Mayya Alexandrovna Dymova et al. Cancer Communications
- Terminal Mono- and Bis-Conjugates of Oligonucleotides with Closo-Dodecaborate: Synthesis and Physico-Chemical Properties
- (2020) Darya S. Novopashina et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era
- (2019) Minoru Suzuki International Journal of Clinical Oncology
- Novel Convenient Approach to the Solid-Phase Synthesis of Oligonucleotide Conjugates
- (2019) Mariya I. Meschaninova et al. MOLECULES
- Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
- (2019) Fadwa Odeh et al. MOLECULES
- Glioblastoma Treatments: An Account of Recent Industrial Developments
- (2018) Edouard Alphandéry Frontiers in Pharmacology
- Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications
- (2017) Emma Hays et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Radiobiological response of U251MG, CHO-K1 and V79 cell lines to accelerator-based boron neutron capture therapy
- (2017) Eisuke Sato et al. JOURNAL OF RADIATION RESEARCH
- iCELLigence real-time cell analysis system for examining the cytotoxicity of drugs to cancer cell lines
- (2017) Leyla Türker Şener et al. Experimental and Therapeutic Medicine
- Selective Targeting to Glioma with Nucleic Acid Aptamers
- (2015) Shraddha Aptekar et al. PLoS One
- Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFRβ Aptamer
- (2014) Simona Camorani et al. MOLECULAR THERAPY
- Targeting Axl With an High-affinity Inhibitory Aptamer
- (2012) Laura Cerchia et al. MOLECULAR THERAPY
- A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death
- (2011) Carla Lucia Esposito et al. PLoS One
- Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax
- (2010) Peng Wang et al. BMC CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now